A Drug Dismantles a Metabolic Barrier to Anti-Tumor Immunity
A Ludwig Cancer Research study has identified a specific mode of fat uptake by immune cells within tumors that serves as a metabolic checkpoint against anti-cancer immune responses.
28-Apr-2025 6:40 PM EDT
Add to Favorites